Review article: emerging drug therapies in inflammatory bowel disease.

Laurie B Grossberg Konstantinos Papamichael Adam S Cheifetz

Published in: Alimentary pharmacology & therapeutics (2022)

Several new IBD drug therapies have positive efficacy and safety data in early clinical trials, and there are several drugs in the therapeutic pipeline. As more treatments for CD and UC are approved for clinical use, research to assess predictors of response to therapy and head-to-head trials is needed to inform providers on how to best position therapeutic options for patients with IBD.

Keyphrases

clinical trial
optic nerve
drug induced
adverse drug
electronic health record
ulcerative colitis
big data
randomized controlled trial
emergency department
machine learning